Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;52:215-217
Published online before print June 9, 2008, doi: 10.1161/HYPERTENSIONAHA.107.108902
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
52/2/215    most recent
HYPERTENSIONAHA.107.108902v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bohlen, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bohlen, H. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Hypertension - basic studies
Right arrow Peripheral vascular disease
Right arrow Glucose intolerance
Right arrowRelated Article

(Hypertension. 2008;52:215.)
© 2008 American Heart Association, Inc.


Editorial Commentaries

Metalloproteinases Damage the Insulin Receptor to Cause Insulin Resistance in Spontaneously Hypertensive Rats

H. Glenn Bohlen

From the Department of Cellular and Integrative Physiology, Indiana University Medical School, Indianapolis.

Correspondence to H. Glenn Bohlen, Department of Cellular and Integrative Physiology, Indiana University Medical School, 635 Barnhill Dr, Indianapolis, IN 46202. E-mail gbohlen@iupui.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The elegant study by Delano and Schmid-Schönbein1 points to a potentially very important overlap of an insulin resistance mechanism with hypertension in the spontaneously hypertensive rat (SHR). Their investigation will likely be important to both the obese and hypertensive populations. With the national and international emphasis on obesity and its attendant cardiovascular problems, there is a tendency to forget that essential hypertension affects about the same percentage of humans as does serious obesity and an even higher percentage of the population than does type 2 diabetes mellitus. Obesity leading to insulin resistance and, in severe situations, type 2 diabetes mellitus, does have a genetic predisposition that the patient’s lifestyle can mitigate. However, hypertension even in the lean population has an established genetic basis and often develops despite every attempt to avoid inappropriate lifestyle issues. There is obviously an overlap of the obese and hypertensive genetic populations and likely a sharing of some mechanisms to cause many of their common vascular and cardiac pathologies.

The existence of insulin resistance in the SHR came to attention in 1988 by a study by Horl et al.2 At the time, this seemed rather unusual, because the SHR is generally quite lean, and the dependence of insulin resistance on some degree of obesity was a common concept. In 1991, Reaven and Chang3 and Reaven4 questioned whether the insulin resistance leads to hypertension or vice versa in the SHR and hypertensive humans. The interest in hypertension and insulin resistance since 1988 has generated >200 articles dealing . . . [Full Text of this Article]


Related Article:

Proteinase Activity and Receptor Cleavage: Mechanism for Insulin Resistance in the Spontaneously Hypertensive Rat
Frank A. DeLano and Geert W. Schmid-Schönbein
Hypertension 2008 52: 415-423. [Abstract] [Full Text] [PDF]